AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 79 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BlackRock Inc. | 2,453,773 | $2,797,302 | 0.00% |
| Bank of New York Mellon Corp | 71,830 | $81,886 | 0.00% |
| ENVESTNET ASSET MANAGEMENT INC | 14,274 | $16,272 | 0.00% |
| Citadel Advisors | 128,300 | $146,262 | 0.00% |
| Citadel Advisors | 53,200 | $60,648 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 149,900 | $170,886 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 135,600 | $154,584 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 750,441 | $855,503 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 16,903 | $19,269 | 0.00% |
| GTS SECURITIES LLC | 79,200 | $90,288 | 0.00% |
| HighTower Advisors, LLC | 95,350 | $109,000 | 0.00% |
| Johnson Financial Group, Inc. | 1,400 | $1,596 | 0.00% |
| Qube Research & Technologies Ltd | 121,416 | $138,414 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,175 | $1,339 | 0.00% |
| Truvestments Capital LLC | 756 | $862 | 0.00% |
| Hexagon Capital Partners LLC | 186 | $212 | 0.00% |
| JPMORGAN CHASE & CO | 94,849 | $108,128 | 0.00% |
| Creative Planning | 110,428 | $125,888 | 0.00% |
| Allworth Financial LP | 748 | $853 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 561 | $640 | 0.00% |
External links
This page lists AKEBIA THERAPEUTICS INC's shareholders in Q3 2023. To view AKEBIA THERAPEUTICS INC's shareholder history, click here.